Camizestrant TFA
Camizestrant TFA (AZD-9833 TFA) is an orally bioavailable, potent estrogen receptor (ER) antagonist used in research. It is employed in preclinical studies to investigate ER-positive cancers, demonstrating activity in both cellular assays and in vivo tumor models.
Product Specifications
Product Name Alternative
AZD-9833 TFA, Camizestrant TFA, Camizestrant TFA (2222844-89-3 Free base), EstrogenReceptor, estrogen receptor, Estrogen Receptor, ERR
Field of Research
Immunology & Inflammation, Metabolism Research
Purity
98.90% (May vary between batches)
Solubility
DMSO:70 mg/mL (118.54 mM)
Smiles
FC (F) (F) CN1[C@H] (C2=CC=C (C=N2) NC3CN (C3) CCCF) C4=C (C[C@H]1C) C5=C (NN=C5) C=C4.O=C (O) C (F) (F) F
Molecular Formula
C26H29F7N6O2
Molecular Weight
590.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15110247 1 Vial
Lentiviral mouse Rrad shRNA (UAS) - Lentiviral mouse Rrad shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 
H7651-05B-ML750 100 µL
HSC70 Interacting Protein (HIP, AAG2, FAM10A1, FAM10A4, FLJ27260, HOP, HSPABP, HSPABP1, MGC129952, P48, PRO0786, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, SNC6, ST13, Suppression of Tumorigenicity 13 Protein (Colon Carcinoma) ) (MaxLight 750) discontinued
Sign In for Pricing
View Details 